{"References": [{"title": "Combination immunotherapy: targeting both innate and adaptive immunity with anti-tumor antibodies", "authors": "Mark S. Cragg, James V. Bonner, Stephen A. Beers", "journal": "Cancer Immunology, Immunotherapy", "year": "2020", "volumes": "69", "first page": "1957", "last page": "1967", "DOI": "10.1007/s00262-020-02595-1"}, {"title": "NK cells and cancer immunotherapy: implications for NK-cell-mediated check point inhibition", "authors": "Eric Vivier, David Artis, Michael Colonna, Marco Diefenbach, E. John Wherry", "journal": "Nature Reviews Immunology", "year": "2018", "volumes": "18", "first page": "87", "last page": "100", "DOI": "10.1038/nri.2017.96"}, {"title": "Harnessing NK cells for cancer immunotherapy: target selection and strategies to overcome limitations", "authors": "Michael A. Caligiuri, Jeffrey S. Miller, Lewis L. Lanier", "journal": "Nature Reviews Drug Discovery", "year": "2017", "volumes": "16", "first page": "85", "last page": "99", "DOI": "10.1038/nrd.2016.193"}, {"title": "The role of T cells in cancer immunotherapy", "authors": "Antoni Ribas, James P. Allison", "journal": "Nature Reviews Clinical Oncology", "year": "2019", "volumes": "16", "first page": "356", "last page": "373", "DOI": "10.1038/s41571-019-0184-2"}, {"title": "Natural killer cells in cancer biology and therapy", "authors": "Christian Romagn√©, Eric Vivier", "journal": "Nature Reviews Cancer", "year": "2019", "volumes": "19", "first page": "112", "last page": "124", "DOI": "10.1038/s41568-018-0094-8"}, {"title": "Checkpoint blockade in cancer immunotherapy", "authors": "James P. Allison, Padmanee Sharma", "journal": "Nature Reviews Cancer", "year": "2016", "volumes": "16", "first page": "109", "last page": "120", "DOI": "10.1038/nrc.2016.1"}, {"title": "The emerging role of NK cells in cancer immunotherapy", "authors": "Lewis L. Lanier", "journal": "Nature Medicine", "year": "2015", "volumes": "21", "first page": "1332", "last page": "1334", "DOI": "10.1038/nm.3991"}, {"title": "T cell-mediated cancer immunotherapy: past, present, and future", "authors": "Carl H. June, Michel Sadelain", "journal": "Nature Reviews Immunology", "year": "2018", "volumes": "18", "first page": "699", "last page": "716", "DOI": "10.1038/s41577-018-0041-6"}, {"title": "NK cell-based cancer immunotherapy: from bench to bedside", "authors": "Jeffrey S. Miller, Michael A. Caligiuri", "journal": "Cancer Immunology Research", "year": "2015", "volumes": "3", "first page": "1109", "last page": "1114", "DOI": "10.1158/2326-6066.CIR-15-0096"}, {"title": "The interplay between innate and adaptive immunity in cancer immunotherapy", "authors": "Laurence Zitvogel, Guido Kroemer", "journal": "Nature Reviews Immunology", "year": "2019", "volumes": "19", "first page": "61", "last page": "76", "DOI": "10.1038/s41577-018-0081-z"}]}